APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Long-acting Reversible Contraceptives (LARCs)

Compare research editions
View pricing & licenses

Selected research

Industry Research

Long-acting Reversible Contraceptives (LARCs) Industry Research Report 2026

Report ID 17442606014 July 2026138 pages

Choose your research edition.

Industry ResearchLong-acting Reversible Contraceptives (LARCs) Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Long-acting Reversible Contraceptives (LARCs) Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Long-acting Reversible Contraceptives (LARCs) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Long-acting Reversible Contraceptives (LARCs) Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Long-acting Reversible Contraceptives (LARCs) Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Long-acting Reversible Contraceptives (LARCs) market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Long-acting Reversible Contraceptives (LARCs) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Long-acting Reversible Contraceptives (LARCs) is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Long-acting Reversible Contraceptives (LARCs) is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Long-acting Reversible Contraceptives (LARCs) include AbbVie Allergan, ASPIVIX, Cooper Companies, Durbin, H & J Medical, HRA Pharma, Laboratoire 7 MED, Laboratoire CCD and OCON, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Long-acting Reversible Contraceptives (LARCs) market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Long-acting Reversible Contraceptives (LARCs) Market by Company

AbbVie Allergan

ASPIVIX

Cooper Companies

Durbin

H & J Medical

HRA Pharma

Laboratoire 7 MED

Laboratoire CCD

OCON

Pregna

Prosan

Shanghai Dahua Pharmaceuticals

Williams Medical Supplies

Yantai JiShengYaoXie

Bayer

Merck

Long-acting Reversible Contraceptives (LARCs) Segment by Type

Copper Intrauterine Devices

Hormonal Intrauterine Devices

Contraceptive Implants

Others

Long-acting Reversible Contraceptives (LARCs) Segment by Application

Age 20-24

Age 25-34

Age 35-44

Others

Long-acting Reversible Contraceptives (LARCs) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Long-acting Reversible Contraceptives (LARCs) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Long-acting Reversible Contraceptives (LARCs) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Long-acting Reversible Contraceptives (LARCs).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Long-acting Reversible Contraceptives (LARCs) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Long-acting Reversible Contraceptives (LARCs) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Long-acting Reversible Contraceptives (LARCs) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Long-acting Reversible Contraceptives (LARCs) Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Long-acting Reversible Contraceptives (LARCs) Sales (k units) of Manufacturers (2021-2026) Table 7. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Manufacturers (2021-2026) Table 8. Global Long-acting Reversible Contraceptives (LARCs) Revenue of Manufacturers (2021-2026) Table 9. Global Long-acting Reversible Contraceptives (LARCs) Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Long-acting Reversible Contraceptives (LARCs) Average Price (USD/unit) of Manufacturers (2021-2026) Table 11. Global Long-acting Reversible Contraceptives (LARCs) Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Long-acting Reversible Contraceptives (LARCs), Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Long-acting Reversible Contraceptives (LARCs), Product Type & Application Table 14. Global Long-acting Reversible Contraceptives (LARCs) Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Long-acting Reversible Contraceptives (LARCs) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. AbbVie Allergan Company Information Table 19. AbbVie Allergan Business Overview Table 20. AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 21. AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 22. AbbVie Allergan Recent Developments Table 23. ASPIVIX Company Information Table 24. ASPIVIX Business Overview Table 25. ASPIVIX Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 26. ASPIVIX Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 27. ASPIVIX Recent Developments Table 28. Cooper Companies Company Information Table 29. Cooper Companies Business Overview Table 30. Cooper Companies Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 31. Cooper Companies Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 32. Cooper Companies Recent Developments Table 33. Durbin Company Information Table 34. Durbin Business Overview Table 35. Durbin Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 36. Durbin Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 37. Durbin Recent Developments Table 38. H & J Medical Company Information Table 39. H & J Medical Business Overview Table 40. H & J Medical Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 41. H & J Medical Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 42. H & J Medical Recent Developments Table 43. HRA Pharma Company Information Table 44. HRA Pharma Business Overview Table 45. HRA Pharma Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 46. HRA Pharma Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 47. HRA Pharma Recent Developments Table 48. Laboratoire 7 MED Company Information Table 49. Laboratoire 7 MED Business Overview Table 50. Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 51. Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 52. Laboratoire 7 MED Recent Developments Table 53. Laboratoire CCD Company Information Table 54. Laboratoire CCD Business Overview Table 55. Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 56. Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 57. Laboratoire CCD Recent Developments Table 58. OCON Company Information Table 59. OCON Business Overview Table 60. OCON Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 61. OCON Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 62. OCON Recent Developments Table 63. Pregna Company Information Table 64. Pregna Business Overview Table 65. Pregna Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 66. Pregna Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 67. Pregna Recent Developments Table 68. Prosan Company Information Table 69. Prosan Business Overview Table 70. Prosan Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 71. Prosan Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 72. Prosan Recent Developments Table 73. Shanghai Dahua Pharmaceuticals Company Information Table 74. Shanghai Dahua Pharmaceuticals Business Overview Table 75. Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 77. Shanghai Dahua Pharmaceuticals Recent Developments Table 78. Williams Medical Supplies Company Information Table 79. Williams Medical Supplies Business Overview Table 80. Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 82. Williams Medical Supplies Recent Developments Table 83. Yantai JiShengYaoXie Company Information Table 84. Yantai JiShengYaoXie Business Overview Table 85. Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 87. Yantai JiShengYaoXie Recent Developments Table 88. Bayer Company Information Table 89. Bayer Business Overview Table 90. Bayer Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Bayer Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 92. Bayer Recent Developments Table 93. Merck Company Information Table 94. Merck Business Overview Table 95. Merck Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Merck Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 97. Merck Recent Developments Table 98. Global Long-acting Reversible Contraceptives (LARCs) Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 99. Global Long-acting Reversible Contraceptives (LARCs) Sales by Region (2021-2026) & (k units) Table 100. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Region (2021-2026) Table 101. Global Long-acting Reversible Contraceptives (LARCs) Sales by Region (2027-2032) & (k units) Table 102. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Region (2027-2032) Table 103. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Region (2021-2026) & (US$ Million) Table 104. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Region (2021-2026) Table 105. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Region (2027-2032) & (US$ Million) Table 106. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Region (2027-2032) Table 107. North America Long-acting Reversible Contraceptives (LARCs) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. North America Long-acting Reversible Contraceptives (LARCs) Sales by Country (2021-2026) & (k units) Table 109. North America Long-acting Reversible Contraceptives (LARCs) Sales by Country (2027-2032) & (k units) Table 110. North America Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2021-2026) & (US$ Million) Table 111. North America Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2027-2032) & (US$ Million) Table 112. Europe Long-acting Reversible Contraceptives (LARCs) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Europe Long-acting Reversible Contraceptives (LARCs) Sales by Country (2021-2026) & (k units) Table 114. Europe Long-acting Reversible Contraceptives (LARCs) Sales by Country (2027-2032) & (k units) Table 115. Europe Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2021-2026) & (US$ Million) Table 116. Europe Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2027-2032) & (US$ Million) Table 117. Asia Pacific Long-acting Reversible Contraceptives (LARCs) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Asia Pacific Long-acting Reversible Contraceptives (LARCs) Sales by Country (2021-2026) & (k units) Table 119. Asia Pacific Long-acting Reversible Contraceptives (LARCs) Sales by Country (2027-2032) & (k units) Table 120. Asia Pacific Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2021-2026) & (US$ Million) Table 121. Asia Pacific Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2027-2032) & (US$ Million) Table 122. South America Long-acting Reversible Contraceptives (LARCs) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. South America Long-acting Reversible Contraceptives (LARCs) Sales by Country (2021-2026) & (k units) Table 124. South America Long-acting Reversible Contraceptives (LARCs) Sales by Country (2027-2032) & (k units) Table 125. South America Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2021-2026) & (US$ Million) Table 126. South America Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2027-2032) & (US$ Million) Table 127. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales by Country (2021-2026) & (k units) Table 129. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales by Country (2027-2032) & (k units) Table 130. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2021-2026) & (US$ Million) Table 131. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2027-2032) & (US$ Million) Table 132. Global Long-acting Reversible Contraceptives (LARCs) Sales by Type (2021-2026) & (k units) Table 133. Global Long-acting Reversible Contraceptives (LARCs) Sales by Type (2027-2032) & (k units) Table 134. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Type (2021-2026) Table 135. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Type (2027-2032) Table 136. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Type (2021-2026) & (US$ Million) Table 137. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Type (2027-2032) & (US$ Million) Table 138. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Type (2021-2026) Table 139. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Type (2027-2032) Table 140. Global Long-acting Reversible Contraceptives (LARCs) Price by Type (2021-2026) & (USD/unit) Table 141. Global Long-acting Reversible Contraceptives (LARCs) Price by Type (2027-2032) & (USD/unit) Table 142. Global Long-acting Reversible Contraceptives (LARCs) Sales by Application (2021-2026) & (k units) Table 143. Global Long-acting Reversible Contraceptives (LARCs) Sales by Application (2027-2032) & (k units) Table 144. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Application (2021-2026) Table 145. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Application (2027-2032) Table 146. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Application (2021-2026) & (US$ Million) Table 147. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Application (2027-2032) & (US$ Million) Table 148. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Application (2021-2026) Table 149. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Application (2027-2032) Table 150. Global Long-acting Reversible Contraceptives (LARCs) Price by Application (2021-2026) & (USD/unit) Table 151. Global Long-acting Reversible Contraceptives (LARCs) Price by Application (2027-2032) & (USD/unit) Table 152. Key Raw Materials Table 153. Raw Materials Key Suppliers Table 154. Long-acting Reversible Contraceptives (LARCs) Distributors List Table 155. Long-acting Reversible Contraceptives (LARCs) Customers List Table 156. Long-acting Reversible Contraceptives (LARCs) Industry Trends Table 157. Long-acting Reversible Contraceptives (LARCs) Industry Drivers Table 158. Long-acting Reversible Contraceptives (LARCs) Industry Restraints Table 159. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Long-acting Reversible Contraceptives (LARCs) Product Image Figure 5. Global Long-acting Reversible Contraceptives (LARCs) Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Long-acting Reversible Contraceptives (LARCs) Market Size (2021-2032) & (US$ Million) Figure 7. Global Long-acting Reversible Contraceptives (LARCs) Sales (2021-2032) & (k units) Figure 8. Global Long-acting Reversible Contraceptives (LARCs) Average Price (USD/unit) & (2021-2032) Figure 9. Copper Intrauterine Devices Product Image Figure 10. Hormonal Intrauterine Devices Product Image Figure 11. Contraceptive Implants Product Image Figure 12. Others Product Image Figure 13. Age 20-24 Product Image Figure 14. Age 25-34 Product Image Figure 15. Age 35-44 Product Image Figure 16. Others Product Image Figure 17. Global Long-acting Reversible Contraceptives (LARCs) Revenue Share by Manufacturers in 2025 Figure 18. Global Manufacturers of Long-acting Reversible Contraceptives (LARCs), Manufacturing Sites & Headquarters Figure 19. Global Top 5 and 10 Long-acting Reversible Contraceptives (LARCs) Players Market Share by Revenue in 2025 Figure 20. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Long-acting Reversible Contraceptives (LARCs) Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 22. Global Long-acting Reversible Contraceptives (LARCs) Sales by Region in 2025 Figure 23. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Region in 2025 Figure 24. North America Long-acting Reversible Contraceptives (LARCs) Market Size by Country in 2025 Figure 25. North America Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Country (2021-2032) Figure 26. North America Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Country (2021-2032) Figure 27. United States Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Canada Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Mexico Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Europe Long-acting Reversible Contraceptives (LARCs) Market Size by Country in 2025 Figure 31. Europe Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Country (2021-2032) Figure 32. Europe Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Country (2021-2032) Figure 33. Germany Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. France Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. U.K. Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Italy Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Russia Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Spain Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Netherlands Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Switzerland Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Sweden Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Poland Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Asia Pacific Long-acting Reversible Contraceptives (LARCs) Market Size by Country in 2025 Figure 44. Asia Pacific Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Country (2021-2032) Figure 45. Asia Pacific Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Country (2021-2032) Figure 46. China Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Japan Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. South Korea Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. India Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Australia Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Taiwan Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Southeast Asia Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. South America Long-acting Reversible Contraceptives (LARCs) Market Size by Country in 2025 Figure 55. South America Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Country (2021-2032) Figure 56. South America Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Country (2021-2032) Figure 57. Brazil Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Argentina Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Chile Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Market Size by Country in 2025 Figure 61. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Country (2021-2032) Figure 62. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Country (2021-2032) Figure 63. Egypt Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. South Africa Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Israel Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Türkiye Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. GCC Countries Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Type (2021-2032) Figure 69. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Type (2021-2032) Figure 70. Global Long-acting Reversible Contraceptives (LARCs) Price (USD/unit) by Type (2021-2032) Figure 71. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Application (2021-2032) Figure 72. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Application (2021-2032) Figure 73. Global Long-acting Reversible Contraceptives (LARCs) Price (USD/unit) by Application (2021-2032) Figure 74. Long-acting Reversible Contraceptives (LARCs) Value Chain Figure 75. Long-acting Reversible Contraceptives (LARCs) Production Mode & Process Figure 76. Direct Comparison with Distribution Share Figure 77. Distributors Profiles Figure 78. Long-acting Reversible Contraceptives (LARCs) Industry Opportunities and Challenges

Scope & coverage.

Types
  • Copper Intrauterine Devices
  • Hormonal Intrauterine Devices
  • Contraceptive Implants
  • Others
Applications
  • Age 20-24
  • Age 25-34
  • Age 35-44
  • Others
Companies covered
  • AbbVie Allergan
  • ASPIVIX
  • Cooper Companies
  • Durbin
  • H & J Medical
  • HRA Pharma
  • Laboratoire 7 MED
  • Laboratoire CCD
  • OCON
  • Pregna
  • Prosan
  • Shanghai Dahua Pharmaceuticals
  • Williams Medical Supplies
  • Yantai JiShengYaoXie
  • Bayer
  • Merck

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Long-acting Reversible Contraceptives (LARCs) Market Size (2021-2032)
  4. 2.2.2 Global Long-acting Reversible Contraceptives (LARCs) Sales (2021-2032)
  5. 2.2.3 Global Long-acting Reversible Contraceptives (LARCs) Market Average Price (2021-2032)
  6. 2.3 Long-acting Reversible Contraceptives (LARCs) by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Copper Intrauterine Devices
  9. 2.3.3 Hormonal Intrauterine Devices
  10. 2.3.4 Contraceptive Implants
  11. 2.3.5 Others
  12. 2.4 Long-acting Reversible Contraceptives (LARCs) by Application
  13. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  14. 2.4.2 Age 20-24
  15. 2.4.3 Age 25-34
  16. 2.4.4 Age 35-44
  17. 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Long-acting Reversible Contraceptives (LARCs) Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Long-acting Reversible Contraceptives (LARCs) Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Long-acting Reversible Contraceptives (LARCs) Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Long-acting Reversible Contraceptives (LARCs) Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Long-acting Reversible Contraceptives (LARCs) Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Long-acting Reversible Contraceptives (LARCs), Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Long-acting Reversible Contraceptives (LARCs), Product Type & Application
  8. 3.8 Global Manufacturers of Long-acting Reversible Contraceptives (LARCs), Established Date
  9. 3.9 Global Long-acting Reversible Contraceptives (LARCs) Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 AbbVie Allergan
  2. 4.1.1 AbbVie Allergan Company Information
  3. 4.1.2 AbbVie Allergan Business Overview
  4. 4.1.3 AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  6. 4.1.5 AbbVie Allergan Recent Developments
  7. 4.2 ASPIVIX
  8. 4.2.1 ASPIVIX Company Information
  9. 4.2.2 ASPIVIX Business Overview
  10. 4.2.3 ASPIVIX Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 ASPIVIX Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  12. 4.2.5 ASPIVIX Recent Developments
  13. 4.3 Cooper Companies
  14. 4.3.1 Cooper Companies Company Information
  15. 4.3.2 Cooper Companies Business Overview
  16. 4.3.3 Cooper Companies Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Cooper Companies Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  18. 4.3.5 Cooper Companies Recent Developments
  19. 4.4 Durbin
  20. 4.4.1 Durbin Company Information
  21. 4.4.2 Durbin Business Overview
  22. 4.4.3 Durbin Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Durbin Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  24. 4.4.5 Durbin Recent Developments
  25. 4.5 H & J Medical
  26. 4.5.1 H & J Medical Company Information
  27. 4.5.2 H & J Medical Business Overview
  28. 4.5.3 H & J Medical Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 H & J Medical Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  30. 4.5.5 H & J Medical Recent Developments
  31. 4.6 HRA Pharma
  32. 4.6.1 HRA Pharma Company Information
  33. 4.6.2 HRA Pharma Business Overview
  34. 4.6.3 HRA Pharma Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 HRA Pharma Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  36. 4.6.5 HRA Pharma Recent Developments
  37. 4.7 Laboratoire 7 MED
  38. 4.7.1 Laboratoire 7 MED Company Information
  39. 4.7.2 Laboratoire 7 MED Business Overview
  40. 4.7.3 Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  42. 4.7.5 Laboratoire 7 MED Recent Developments
  43. 4.8 Laboratoire CCD
  44. 4.8.1 Laboratoire CCD Company Information
  45. 4.8.2 Laboratoire CCD Business Overview
  46. 4.8.3 Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  48. 4.8.5 Laboratoire CCD Recent Developments
  49. 4.9 OCON
  50. 4.9.1 OCON Company Information
  51. 4.9.2 OCON Business Overview
  52. 4.9.3 OCON Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 OCON Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  54. 4.9.5 OCON Recent Developments
  55. 4.10 Pregna
  56. 4.10.1 Pregna Company Information
  57. 4.10.2 Pregna Business Overview
  58. 4.10.3 Pregna Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Pregna Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  60. 4.10.5 Pregna Recent Developments
  61. 4.11 Prosan
  62. 4.11.1 Prosan Company Information
  63. 4.11.2 Prosan Business Overview
  64. 4.11.3 Prosan Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Prosan Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  66. 4.11.5 Prosan Recent Developments
  67. 4.12 Shanghai Dahua Pharmaceuticals
  68. 4.12.1 Shanghai Dahua Pharmaceuticals Company Information
  69. 4.12.2 Shanghai Dahua Pharmaceuticals Business Overview
  70. 4.12.3 Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  72. 4.12.5 Shanghai Dahua Pharmaceuticals Recent Developments
  73. 4.13 Williams Medical Supplies
  74. 4.13.1 Williams Medical Supplies Company Information
  75. 4.13.2 Williams Medical Supplies Business Overview
  76. 4.13.3 Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  78. 4.13.5 Williams Medical Supplies Recent Developments
  79. 4.14 Yantai JiShengYaoXie
  80. 4.14.1 Yantai JiShengYaoXie Company Information
  81. 4.14.2 Yantai JiShengYaoXie Business Overview
  82. 4.14.3 Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  84. 4.14.5 Yantai JiShengYaoXie Recent Developments
  85. 4.15 Bayer
  86. 4.15.1 Bayer Company Information
  87. 4.15.2 Bayer Business Overview
  88. 4.15.3 Bayer Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Bayer Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  90. 4.15.5 Bayer Recent Developments
  91. 4.16 Merck
  92. 4.16.1 Merck Company Information
  93. 4.16.2 Merck Business Overview
  94. 4.16.3 Merck Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Merck Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  96. 4.16.5 Merck Recent Developments
5 Global Long-acting Reversible Contraceptives (LARCs) Market Scenario by Region
  1. 5.1 Global Long-acting Reversible Contraceptives (LARCs) Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Long-acting Reversible Contraceptives (LARCs) Sales by Region: 2021-2032
  3. 5.2.1 Global Long-acting Reversible Contraceptives (LARCs) Sales by Region: 2021-2026
  4. 5.2.2 Global Long-acting Reversible Contraceptives (LARCs) Sales by Region: 2027-2032
  5. 5.3 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Region: 2021-2032
  6. 5.3.1 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Region: 2021-2026
  7. 5.3.2 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Region: 2027-2032
  8. 5.4 North America Long-acting Reversible Contraceptives (LARCs) Market Facts & Figures by Country
  9. 5.4.1 North America Long-acting Reversible Contraceptives (LARCs) Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Long-acting Reversible Contraceptives (LARCs) Sales by Country (2021-2032)
  11. 5.4.3 North America Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Long-acting Reversible Contraceptives (LARCs) Market Facts & Figures by Country
  16. 5.5.1 Europe Long-acting Reversible Contraceptives (LARCs) Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Long-acting Reversible Contraceptives (LARCs) Sales by Country (2021-2032)
  18. 5.5.3 Europe Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Long-acting Reversible Contraceptives (LARCs) Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Long-acting Reversible Contraceptives (LARCs) Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Long-acting Reversible Contraceptives (LARCs) Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Long-acting Reversible Contraceptives (LARCs) Market Facts & Figures by Country
  41. 5.7.1 South America Long-acting Reversible Contraceptives (LARCs) Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Long-acting Reversible Contraceptives (LARCs) Sales by Country (2021-2032)
  43. 5.7.3 South America Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Long-acting Reversible Contraceptives (LARCs) Sales by Type (2021-2032)
  2. 6.1.1 Global Long-acting Reversible Contraceptives (LARCs) Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Type (2021-2032)
  4. 6.2 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Type (2021-2032)
  5. 6.2.1 Global Long-acting Reversible Contraceptives (LARCs) Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Long-acting Reversible Contraceptives (LARCs) Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Long-acting Reversible Contraceptives (LARCs) Sales by Application (2021-2032)
  2. 7.1.1 Global Long-acting Reversible Contraceptives (LARCs) Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Application (2021-2032)
  4. 7.2 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Application (2021-2032)
  5. 7.2.1 Global Long-acting Reversible Contraceptives (LARCs) Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Long-acting Reversible Contraceptives (LARCs) Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Long-acting Reversible Contraceptives (LARCs) Value Chain Analysis
  2. 8.1.1 Long-acting Reversible Contraceptives (LARCs) Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Long-acting Reversible Contraceptives (LARCs) Production Mode & Process
  5. 8.2 Long-acting Reversible Contraceptives (LARCs) Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Long-acting Reversible Contraceptives (LARCs) Distributors
  8. 8.2.3 Long-acting Reversible Contraceptives (LARCs) Customers
9 Global Long-acting Reversible Contraceptives (LARCs) Analyzing Market Dynamics
  1. 9.1 Long-acting Reversible Contraceptives (LARCs) Industry Trends
  2. 9.2 Long-acting Reversible Contraceptives (LARCs) Industry Drivers
  3. 9.3 Long-acting Reversible Contraceptives (LARCs) Industry Opportunities and Challenges
  4. 9.4 Long-acting Reversible Contraceptives (LARCs) Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst